Active Ingredient(s):Dapagliflozin + Saxagliptin FDA Approved: * February 27, 2017 Pharm Company: *ASTRAZENECA AB Category:Diabetes
Dapagliflozin, sold under the brand names Farxiga (US) and Forxiga (EU) among others, is a medication used to treat type 2 diabetes. It is also used to treat adults with certain kinds of heart failure and chronic kidney disease.
Common side effects include hypoglycaemia (low blood sugar), urinary tract infections, genital infections, and volume depletion (reduced amount of water i...
* May have multiple approval dates, manufacturers, or labelers.